We bring you the latest news from the healthcare about the health care in the United Kingdom.

woensdag 14 maart 2018

Neuropsychopharmacology - Table of Contents alert Volume 43 Issue 5

If you are unable to see the message below, click here to view.

Volume 43, Issue 5 (April 2018)

In this issue
Review Article
Original Articles
In Memoriams
Also new


Parvalbumin-Expressing Neurons in the Nucleus Accumbens: A New Player in Amphetamine Sensitization and Reward

Brandon L Warren & Leslie R Whitaker

Neuropsychopharmacology 2017 43 :929 - 930; August 17, 2017; 10.1038/npp.2017.256


Abstract | Full Text

Too Depressed to Swim or Too Afraid to Stop? A Reinterpretation of the Forced Swim Test as a Measure of Anxiety-Like Behavior

Jeffrey Anyan & Shimon Amir

Neuropsychopharmacology 2017 43 :931 - 933; October 31, 2017; 10.1038/npp.2017.260


Abstract | Full Text


CNO Evil? Considerations for the Use of DREADDs in Behavioral Neuroscience

Stephen V Mahler & Gary Aston-Jones

Neuropsychopharmacology 2018 43 :934 - 936; February 07, 2018; 10.1038/npp.2017.299


Abstract | Full Text

Review Article

Neuronal Mechanisms for Sleep/Wake Regulation and Modulatory Drive

Ada Eban-Rothschild, Lior Appelbaum & Luis de Lecea

Neuropsychopharmacology 2017 43 :937 - 952; December 05, 2017; 10.1038/npp.2017.294


Abstract | Full Text

Original Articles

Parvalbumin Interneurons of the Mouse Nucleus Accumbens are Required For Amphetamine-Induced Locomotor Sensitization and Conditioned Place Preference

Xiaoting Wang, David A Gallegos, Vladimir M Pogorelov, Justin K O'Hare, Nicole Calakos et al.

Neuropsychopharmacology 2017 43 :953 - 963; August 25, 2017; 10.1038/npp.2017.178


Abstract | Full Text

Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum

Estefanía Moreno, Anna Chiarlone, Mireia Medrano, Mar Puigdellívol, Lucka Bibic et al.

Neuropsychopharmacology 2017 43 :964 - 977; January 19, 2017; 10.1038/npp.2017.12


Abstract | Full Text

Pituitary Adenylate Cyclase-Activating Peptide in the Bed Nucleus of the Stria Terminalis Mediates Stress-Induced Reinstatement of Cocaine Seeking in Rats

Olivia W Miles, Eric A Thrailkill, Anne K Linden, Victor May, Mark E Bouton et al.

Neuropsychopharmacology 2017 43 :978 - 986; June 28, 2017; 10.1038/npp.2017.135


Abstract | Full Text

Dorsal Hippocampus Drives Context-Induced Cocaine Seeking via Inputs to Lateral Septum

Ellen M McGlinchey & Gary Aston-Jones

Neuropsychopharmacology 2017 43 :987 - 1000; July 11, 2017; 10.1038/npp.2017.144


Abstract | Full Text

Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine

Taylor A Gentile, Steven J Simmons, Mia N Watson, Krista L Connelly, Eugen Brailoiu et al.

Neuropsychopharmacology 2017 43 :1001 - 1009; July 25, 2017; 10.1038/npp.2017.158


Abstract | Full Text

Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence

Alessandra Matzeu, Marsida Kallupi, Olivier George, Paul Schweitzer & Rémi Martin-Fardon

Neuropsychopharmacology 2017 43 :1010 - 1020; October 20, 2017; 10.1038/npp.2017.250


Abstract | Full Text

Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol

Arnau Busquets-Garcia, Maria Gomis-González, Victòria Salgado-Mendialdúa, Lorena Galera-López, Emma Puighermanal et al.

Neuropsychopharmacology 2017 43 :1021 - 1031; August 17, 2017; 10.1038/npp.2017.175


Abstract | Full Text

Selective Lesioning of Nuclear Factor-?B Activated Cells in the Nucleus Accumbens Shell Attenuates Alcohol Place Preference

S E Nennig, H D Fulenwider, S H Chimberoff, B M Smith, J E Eskew et al.

Neuropsychopharmacology 2017 43 :1032 - 1040; September 13, 2017; 10.1038/npp.2017.214


Abstract | Full Text

Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions

Amaia M Erdozain, Stéphanie De Gois, Véronique Bernard, Victor Gorgievski, Nicolas Pietrancosta et al.

Neuropsychopharmacology 2017 43 :1041 - 1051; September 14, 2017; 10.1038/npp.2017.217


Abstract | Full Text

The Effect of Treatment with Guanfacine, an Alpha2 Adrenergic Agonist, on Dopaminergic Tone in Tobacco Smokers: An [11C]FLB457 PET Study

Christine M Sandiego, David Matuskey, Meaghan Lavery, Erin McGovern, Yiyun Huang et al.

Neuropsychopharmacology 2017 43 :1052 - 1058; September 25, 2017; 10.1038/npp.2017.223


Abstract | Full Text

Incubation of Accumbal Neuronal Reactivity to Cocaine Cues During Abstinence Predicts Individual Vulnerability to Relapse

Karine Guillem & Serge H Ahmed

Neuropsychopharmacology 2017 43 :1059 - 1065; September 18, 2017; 10.1038/npp.2017.224


Abstract | Full Text

VTA mTOR Signaling Regulates Dopamine Dynamics, Cocaine-Induced Synaptic Alterations, and Reward

Xiaojie Liu, Yan Li, Laikang Yu, Casey R Vickstrom & Qing-song Liu

Neuropsychopharmacology 2017 43 :1066 - 1077; October 17, 2017; 10.1038/npp.2017.247


Abstract | Full Text

SMRI Biomarkers Predict Electroconvulsive Treatment Outcomes: Accuracy with Independent Data Sets

Rongtao Jiang, Christopher C Abbott, Tianzi Jiang, Yuhui Du, Randall Espinoza et al.

Neuropsychopharmacology 2017 43 :1078 - 1087; July 31, 2017; 10.1038/npp.2017.165


Abstract | Full Text

Narp Mediates Antidepressant-Like Effects of Electroconvulsive Seizures

Andrew D Chang, Punit V Vaidya, Edward P Retzbach, Sunho J Chung, Urian Kim et al.

Neuropsychopharmacology 2017 43 :1088 - 1098; October 20, 2017; 10.1038/npp.2017.252


Abstract | Full Text

Prefrontal Cortex Deep Brain Stimulation Improves Fear and Anxiety-Like Behavior and Reduces Basolateral Amygdala Activity in a Preclinical Model of Posttraumatic Stress Disorder

Roman Reznikov, Francis Rodriguez Bambico, Mustansir Diwan, Roger J Raymond, Mina G Nashed et al.

Neuropsychopharmacology 2017 43 :1099 - 1106; September 01, 2017; 10.1038/npp.2017.207


Abstract | Full Text

Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans

Amelia Draper, Rebecca M Koch, Jos WM van der Meer, Matthew AJ Apps, Peter Pickkers et al.

Neuropsychopharmacology 2017 43 :1107 - 1118; September 26, 2017; 10.1038/npp.2017.231


Abstract | Full Text

Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder

Dustin Scheinost, Sophie E Holmes, Nicole DellaGioia, Charlie Schleifer, David Matuskey et al.

Neuropsychopharmacology 2017 43 :1119 - 1127; September 25, 2017; 10.1038/npp.2017.229


Abstract | Full Text

The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder

Xiao Xiao, Fanfan Zheng, Hong Chang, Yina Ma, Yong-Gang Yao et al.

Neuropsychopharmacology 2017 43 :1128 - 1137; October 09, 2017; 10.1038/npp.2017.241


Abstract | Full Text

Epigenetic Changes of FKBP5 as a Link Connecting Genetic and Environmental Risk Factors with Structural and Functional Brain Changes in Major Depression

Leonardo Tozzi, Chloe Farrell, Linda Booij, Kelly Doolin, Zsofia Nemoda et al.

Neuropsychopharmacology 2017 43 :1138 - 1145; November 28, 2017; 10.1038/npp.2017.290


Abstract | Full Text

Pregenual Anterior Cingulate Dysfunction Associated with Depression in OCD: An Integrated Multimodal fMRI/1H MRS Study

Reza Tadayonnejad, Rangaprakash Deshpande, Olusola Ajilore, Teena Moody, Francesca Morfini et al.

Neuropsychopharmacology 2017 43 :1146 - 1155; October 20, 2017; 10.1038/npp.2017.249


Abstract | Full Text

Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala

Thomas Grund & Inga D Neumann

Neuropsychopharmacology 2017 43 :1156 - 1163; August 14, 2017; 10.1038/npp.2017.169


Abstract | Full Text

Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and ß-Arrestin to Dopamine-Dependent Functions

Samuel J Rose, Thomas F Pack, Sean M Peterson, Kaitlin Payne, Emiliana Borrelli et al.

Neuropsychopharmacology 2017 43 :1164 - 1173; October 25, 2017; 10.1038/npp.2017.254


Abstract | Full Text

The New News about Lithium: An Underutilized Treatment in the United States

Robert M Post

Neuropsychopharmacology 2017 43 :1174 - 1179; October 04, 2017; 10.1038/npp.2017.238


Abstract | Full Text

Brain-Behavior Participant Similarity Networks Among Youth and Emerging Adults with Schizophrenia Spectrum, Autism Spectrum, or Bipolar Disorder and Matched Controls

Laura Stefanik, Lauren Erdman, Stephanie H Ameis, George Foussias, Benoit H Mulsant et al.

Neuropsychopharmacology 2017 43 :1180 - 1188; November 06, 2017; 10.1038/npp.2017.274


Abstract | Full Text

In Memoriams

Larry J Seidman

Matcheri S Keshavan

Neuropsychopharmacology 2018 43 :1189 - 1190; March 14, 2018; 10.1038/npp.2017.288


Abstract | Full Text

Pamela Sklar

Alexander W Charney

Neuropsychopharmacology 2018 43 :1191 - 1192; March 14, 2018; 10.1038/npp.2018.1


Abstract | Full Text

Dennis L Murphy, MD

James B. Potash, Andrew Holmes & Anne Milasincic Andrews

Neuropsychopharmacology 2018 43 :1193 - 1194; March 14, 2018; 10.1038/npp.2018.2


Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature